Impact of Nutritional Counselling in Children With Autism
The Impact of Nutritional Counselling in Children With Autistic Spectrum Disorder
1 other identifier
interventional
20
1 country
1
Brief Summary
Autism Spectrum Disorder (ASD) is a complex group of behavioral disorders characterized by defects in social interaction and communication associated with restricted and repetitive behaviors and activities. The prevalence in pediatric age is continuously increasing in Western countries (58-67 / 10,000). The Diagnostic and Statistical Manual of Mental Disorders version 5 (DSM-5) describes a worldwide population prevalence of approximately 1%. According to the latest data from the National Observatory for the monitoring of ASD, in Italy 1 child out of 77 (age 7-9 years) has the disease with a higher prevalence in males: males are affected 4.4 times more than females . The clinical manifestations of ASD are the result of complex interactions between genetic, epigenetic, environmental and microbiological factors. Alterations in nutritional status, eating habits and adverse reactions to food appear to be more frequent in children with ASD. It is estimated that 46-89% of children with ASD have feeding problems which can include unusual eating patterns, rituals and food selectivity. These types of eating behaviors can lead to severe alterations in nutritional status. Furthermore, the data present in the literature concerning the eating habits of children with ASD suggest a high consumption of "junk food" and foods rich in calories together with a refusal of fruit, vegetables or proteins. These data suggest that the dietary and behavioral problems frequently present in these children could favor a condition of obesity. Finally, a high percentage of children with ASD undergo elimination diets, characterized by exclusions of foods relevant to the diet of a child such as milk and gluten to alleviate the symptoms of the disease. Such elimination diets are only rarely supervised by a nutritionist with further consequences on nutritional status.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2020
CompletedFirst Submitted
Initial submission to the registry
November 23, 2020
CompletedFirst Posted
Study publicly available on registry
December 3, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2022
CompletedDecember 3, 2020
December 1, 2020
Same day
November 23, 2020
December 2, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Adherence to Mediterranean Diet
Evaluation of mediterranea diet through score aiming to assess the mediterranean diet adhesion (Kidmed score; minimum value 0-worse maximum value 12-better)
change from baseline at 12 months
Secondary Outcomes (2)
Change in food selectivity
change from baseline at 12 months
Change in eating habits
change from baseline at 12 months
Other Outcomes (1)
change in auxological parameters
change from baseline at 12 months
Study Arms (2)
Nutritional counseling
EXPERIMENTALChildren with autism spectrum disorders to whom administer nutritional counseling
Controls
NO INTERVENTIONNo intervention
Interventions
Nutritional counseling about mediterranean diet
Eligibility Criteria
You may qualify if:
- diagnosis of autism spectrum disorders
You may not qualify if:
- Age at enrollment \<24 or\> 48 months.
- Concomitant presence of other chronic diseases
- epilepsy,
- neurological syndromes,
- immunodeficiencies,
- diabetes,
- congenital heart disease,
- autoimmune diseases,
- inborn errors of metabolism,
- tuberculosis,
- cystic fibrosis,
- chronic respiratory tract diseases,
- inflammatory bowel disease,
- celiac disease,
- eosinophilic pathologies of the gastrointestinal tract,
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Naples Federico II
Naples, 80131, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief of the Pediatric Allergy Program at the Department of Translational Medical Science Chief of the ImmunoNutritionLab at CEINGE - Advanced Biotechnologies
Study Record Dates
First Submitted
November 23, 2020
First Posted
December 3, 2020
Study Start
September 1, 2020
Primary Completion
September 1, 2020
Study Completion
September 1, 2022
Last Updated
December 3, 2020
Record last verified: 2020-12